Integrated Insights.
Get the right answers to the right questions.
What we do.
Our approach emphasizes rigor from start to finish, delivering thoughtful, fact-based answers to your most critical questions.
We bring a hypothesis-driven approach that uses a range of primary and secondary market research sources and approaches to deliver actionable insights tailored to your specific needs with market context.
Our strong relationships with in-country partners enable us to support nearly all life science markets and understand the nuances that impact insight gathering and methodological design. Our life science integrated insights expertise supports our core offerings.
Our life science integrated insights expertise supports our core offerings:
- Research methodology design and application: Customized approach to each project anchored in a deep understanding of audiences and feasibility, the best research methodology (quantitative and qualitative) for your strategic needs, and a patient-centered research approach
- Fieldwork execution: Proprietary panel of stakeholders across the healthcare ecosystem, including HCPs/treaters, patients/caregivers, allied healthcare stakeholders/non-treaters, and payers
- Robust analysis and data QC: Rigorous measures ensure robustness and validation of output
- Synthesis and output: Maximized insights coupled with strategic recommendations
Our integrated insights pillars.
Global – Research in 50+ markets.
Diverse – Breadth of insights experience in therapeutic areas, disease subtypes, and stakeholder types.
Custom – Fit-for-purpose project methodology ensures focus on the right questions for the right answers.
Comprehensive – 200+ projects per year with the methodology to fit client needs. Qualitative, quantitative, and hybrid.
Functional expertise.
We are experts at identifying, collecting, and analyzing the appropriate insights to inform confident decision making.
Featured case study
Global vaccine forecasting.
Latest thinking.
Get the latest insights and perspectives from our experts.
-
Read more
Global vaccine forecasting
Stay ahead in vaccine market strategy as competitor's halt forces Putnam's client to adapt global forecasts for dynamic launch scenarios.
-
Read more
Dynamic disease modeling in NSCLC
The client with a focus on developing pipeline asset for KRAS G12C segment sought granular insights for competitive edge in treatment sequencing.
-
Read more
Long-term strategy for cellular therapy
The organization engaged Putnam to support the development of 10-year strategy, focused on continuous innovation across all aspects of the business.
-
Read more
Unlocking the promise of cell therapies for solid tumors: Opportunities and challenges
Our cell and gene therapy experts offer a deep analysis on the current opportunities and challenges of cell therapies for solid tumors.
Get in touch.
Looking to get in touch with an expert or team member? Tell us how we can help.